Significats de mucosal melanoma en anglès

Our results support the role of these antigens in immunotherapy for mucosal melanoma.

Rates of mucosal melanoma were approximately two times higher among whites compared with blacks.

Patients with mucosal melanoma may be offered the same therapies recommended for cutaneous melanoma.

Little is known about the prognostic significance as well as possible associations between PARP1 and immunologic response in mucosal melanoma.

Conclusions: Our concept of histogenesis of mucosal melanoma assists in the identification of this highly malignant neoplasm in the early curable stages.

Moreover, a robust correlation between MET and PD-L1 expression was found in samples from metastatic melanoma and not in primary cutaneous or mucosal melanoma.

The association between PARP1 and IDO1 and their combined adverse prognostic role raise the potential of combined therapy in mucosal melanoma.

Conclusion: Increased expression of PARP1 is an independent negative prognostic marker in mucosal melanomas.

Conclusions: Mucosal melanoma of the female genital tract is an aggressive and often fatal disease.

Mucosal melanomas formed a distinct group with increased expression of cell cycle and proliferation genes.

Introduction: Mucosal melanoma is rare and associated with poorer prognosis in comparison to conventional melanoma subtypes.

Mucosal melanomas have upregulation in cell cycle and proliferation genes, which may explain their aggressive behavior.

Primary mucosal melanomas are rare, biologically aggressive neoplasms.

We hypothesize that mucosal melanomas, recognized for their uniquely aggressive clinical behavior, have distinct genomic features.

Mucosal melanoma is a rare disease, which differs from its cutaneous counterpart genetically and for its clinical behaviour.

Background: Mucosal melanoma of the female genital tract that recurs locally after definitive surgery presents difficult challenges for salvage therapy.